| Product Name | MF | CAS | Details |
|---|
| TETRACYCLO[7.1.0.0(2,4).0(5,7)]DEC-8-YL 3,5-DINITROBENZOATE ISOMER 2 | Details |
| 3-METHYL-1-(N-(4-NITROPHENYL)CARBAMOYL)PIPERIDINE | 200394-42-9 | Details |
| 5-(3-(4-FLUOROPHENYL)ACRYLOYL)-2-HYDROXYBENZOIC ACID | 157231-31-7 | Details |
| 3-Bromothianaphthene | C8H5BrS | 7342-82-7 | Details |
| 6-AMINO-1-(3-CHLOROPHENYL)-4-(2,4-DICHLOROPHENYL)-3-METHYL-1,4-DIHYDROPYRANO[2,3-C]PYRAZOLE-5-CARBONITRILE | C20H13Cl3N4O | 317841-76-2 | Details |
| N-(1-(1,1-DIOXO-4H-THIOPHEN-3-YLCARBAMOYL)-2-FURAN-2-YL-VINYL)-4-ME-BENZAMIDE | C19H20N2O5S | 297142-67-7 | Details |
| Monoclonal Anti-Syntaxin antibody produced in mouse | Details |
| 2-(4-BENZYL-1-PIPERAZINYL)-N'-(3-CHLOROBENZYLIDENE)ACETOHYDRAZIDE | C20H23ClN4O | 315182-79-7 | Details |
| ETHYL 3-(2-NAPHTHOYL)PYRROLO(1,2-C)QUINAZOLINE-1-CARBOXYLATE | C25H18N2O3 | 892157-23-2 | Details |
| Poly(1,3-propylene glutarate) | C8H16O6 | 52256-48-1 | Details |
| ISOBUTYL (2E)-2-(4-FLUOROBENZYLIDENE)-7-METHYL-3-OXO-5-(2-THIENYL)-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE | C23H21FN2O3S2 | 518985-59-6 | Details |
| C.I. 909 NAPTHOL BLUE 3 R CONC. | Details |
| 4-(4-BR-PHENYL)-2-P-TOLYL-1,9B-DIHYDRO-5-OXA-3,3A-DIAZA-CYCLOPENTA(A)NAPHTHALENE | C23H19BrN2O | 332061-01-5 | Details |
| β-Boswellic acid | C30H48O3 | 631-69-6 | Details |
| Boceprevir | C27H45N5O5 | 394730-60-0 | Details |
| 2,5-BIS(2-ETHYLANILINO)-3,6-DICHLORO-1,4-BENZOQUINONE | C22H20Cl2N2O2 | 195195-83-6 | Details |
| 3-[(Z)-(3-CYCLOHEXYL-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-[(3-METHOXYPROPYL)AMINO]-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C22H26N4O3S2 | 380595-41-5 | Details |
| GASKET, FLAT, VANTAGE, 8MM X 4.8MM X 2.1MM, SANTOPRENE, SET OF 10 | Details |
| Anti-LEFTY2 antibody produced in mouse | Details |
| Bupropion Hydrochloride Related Compound C | C9H9ClO2 | 152943-33-4 | Details |
| 4-ET-2-((4-ET-3,5-DI-ME-1H-PYRROL-2-YL)METHYLENE)-3,5-DI-ME-2H-PYRROLIUM BROMIDE | C17H24BrN2+ | 151464-97-0 | Details |
| Coated Wire Tube Rack | Details |
| N'-[(E,2Z)-2-BROMO-3-PHENYL-2-PROPENYLIDENE]-2-{[4-(4-METHYLPHENYL)-5-PHENYL-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}ACETOHYDRAZIDE | C26H22BrN5OS | 306286-64-6 | Details |
| Cobalt(II) acetylacetonate hydrate | C10H14CoO4 | 123334-29-2 | Details |
| 2-{[3-(4-CHLOROPHENYL)-4-OXO-3,4-DIHYDRO-2-QUINAZOLINYL]SULFANYL}-N-(2-METHYLPHENYL)ACETAMIDE | C23H18ClN3O2S | 431923-16-9 | Details |
| 1,3-BIS-(HYDROXY-PHENYL-P-TOLYL-METHYL)-UREA | 201734-70-5 | Details |
| 2-CHLOROBENZALDEHYDE [3-METHYL-7-(1-NAPHTHYLMETHYL)-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL]HYDRAZONE | C24H19ClN6O2 | 478252-69-6 | Details |
| Protoporphyrin IX | C34H34N4O4 | 553-12-8 | Details |
| Anti-ERICH6B antibody produced in rabbit | Details |
| 2-(Boc-aminomethyl)benzoic acid | C13H17NO4 | 669713-61-5 | Details |
| 2,7,7-TRI-ME-5-OXO-4-(2,4,5-TRI-MEO-PH)-1,4,5,6,7,8-6H-QUINOLINE-3-CARBONITRILE | 883801-65-8 | Details |
| 4'-METHYL-4-NITROCHALCONE | C16H13NO3 | 13736-56-6 | Details |
| Anti-DNAJC17 antibody produced in rabbit | Details |
| methyl {4-[(1Z)-2-nitro-1-propenyl]phenoxy}acetate | C12H13NO5 | 78069-43-9 | Details |
| 3-{(E)-[3-(1,3-BENZODIOXOL-5-YLMETHYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]METHYL}-2-[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]-9-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C27H27N5O5S2 | 519009-66-6 | Details |
| 1-(4-CHLOROBENZYL)-N'-(1-(4-NITROPHENYL)ETHYLIDENE)-1H-PYRAZOLE-3-CARBOHYDRAZIDE | C19H16ClN5O3 | 1006531-53-8 | Details |
| Anti-phospho-Parkin (pSer131) antibody produced in rabbit | Details |
| 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxaldehyde | C11H9FN2O | 423768-41-6 | Details |
| 4-Amino-7-(trifluoromethyl)quinoline | C10H7F3N2 | 243666-11-7 | Details |
| 4-(2-((4-BUTOXYPHENOXY)ACETYL)CARBOHYDRAZONOYL)-2-METHOXYPHENYL 4-BUTOXYBENZOATE | C31H36N2O7 | 880027-07-6 | Details |
| 1-(1,3-BENZODIOXOL-5-YL)-3-((4-BROMOPHENYL)SULFONYL)-1-PROPANONE | C16H13BrO5S | 477334-46-6 | Details |
| 3-HYDROXY-4-(4-METHOXY-2-METHYLBENZOYL)-1-(3-PYRIDINYLMETHYL)-5-(3,4,5-TRIMETHOXYPHENYL)-1,5-DIHYDRO-2H-PYRROL-2-ONE | C28H28N2O7 | 385417-05-0 | Details |
| 1-tritylimidazole-4-carboxaldehyde | C23H18N2O | 33016-47-6 | Details |
| Anti-TRPM5 (AB1) antibody produced in rabbit | Details |
| CIP2A Inhibitor, TD-19 | C30H24N4O3 | 1403933-79-8 | Details |
| Anti-phospho-VE-Cadherin (pTyr731) antibody produced in rabbit | Details |
| Monoclonal Anti-Fluorescein (FITC) IgG, CF 488A antibody produced in mouse | Details |
| METHYL 3-(5-METHYL-2-FURYL)-1H-PYRAZOLE-5-CARBOXYLATE | C10H10N2O3 | 890591-48-7 | Details |
| N'-(2-(BENZYLOXY)BENZYLIDENE)-2-(4-NITROPHENOXY)PROPANOHYDRAZIDE | 374637-56-6 | Details |
| 4-n-Propylphenylmagnesium bromide solution | C9H11BrMg | 87942-08-3 | Details |
| 4-HYDROXY-2-OXO-N'-(2-PYRIDINYLMETHYLENE)-1,2-DIHYDRO-3-QUINOLINECARBOHYDRAZIDE | C16H12N4O3 | 376620-27-8 | Details |
| N-(2-(2-(4-(BENZYLOXY)BENZYLIDENE)HYDRAZINO)-2-OXOETHYL)-3-METHYLBENZAMIDE | C24H23N3O3 | 444648-94-6 | Details |
| (5E)-3-(3-ETHOXYPROPYL)-5-{[3-(4-METHOXY-2-METHYLPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE}-2-THIOXO-1,3-THIAZOLIDIN-4-ONE | C26H27N3O3S2 | 1017530-77-6 | Details |
| Fmoc-Lys(Mtt)-Wang resin LL (100-200 mesh) | Details |
| 4-Hydroxy-3-methoxybenzylamine hydrochloride | C8H12ClNO2 | 7149-10-2 | Details |
| Spiro-2CBP | C49H30N2 | 924899-38-7 | Details |
| 7-(2-CHLOROBENZYL)-8-[4-(3-CHLOROPHENYL)-1-PIPERAZINYL]-3-METHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | C23H22Cl2N6O2 | 442864-47-3 | Details |
| 2-MEO-4-(2-((1-NAPHTHYLAMINO)(OXO)AC)CARBOHYDRAZONOYL)PHENYL 2-CHLOROBENZOATE | C27H20ClN3O5 | 769152-77-4 | Details |
| PrEST Antigen IL12RB1 | Details |
| N'-(4-((4-CHLOROBENZYL)OXY)BENZYLIDENE)-2-(3-CHLOROPHENOXY)PROPANOHYDRAZIDE | C23H20Cl2N2O3 | 767302-24-9 | Details |
| Anti-SLC5A7 antibody produced in rabbit | Details |
| Anti-Rabbit IgG (Fc specific), F(ab′)2 fragment-Alkaline Phosphatase antibody produced in goat | Details |
| 2-PHENOXY-N-(2-PYRIDINYL)ACETAMIDE | C13H12N2O2 | 296266-16-5 | Details |
| O-(N-(3,4-XYLYL)CARBAMOYL)ACETONE OXIME | C12H16N2O2 | 201408-65-3 | Details |
| Butyl stearate | C22H44O2 | 123-95-5 | Details |
| Tris(acetonitrile)cyclopentadienylruthenium(II) hexafluorophosphate | C11H14F6N3PRu5* | 80049-61-2 | Details |
| Residual Solvent Class 2 - Methylbutylketone | C6H12O | 591-78-6 | Details |
| (3S)-3-BROMO-7,7-DIMETHYLBICYCLO[4.1.1]OCT-4-EN-2-ONE | C10H13BrO | 1217500-27-0 | Details |
| {3-[(methylsulfonyl)oxy]-6-oxo-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-2-yl}methyl benzoate | C17H16N2O8S | 1314883-47-0 | Details |
| 1-(2-ISOPROPYL-5-ME-CYCLOHEXYLOXYCARBONYLMETHYL)-3-METHYL-PYRIDINIUM, CHLORIDE | C18H28ClNO2 | 202132-12-5 | Details |
| Anti-Viperin Antibody, clone MaP.VIP | Details |
| PrEST Antigen OTOA | Details |
| Dox-NP (5mL vial) | Details |
| 1,3-DIPHENYL-2-PROPANOL | C15H16O | 5381-92-0 | Details |
| 20X Wash Buffer Concentrate B | Details |
| N-(4-Bromophenyl)methanesulfonamide | C7H8BrNO2S | 4284-50-8 | Details |
| 5-{[(4R)-5-{[TERT-BUTYL(DIMETHYL)SILYL]OXY}-4-(METHOXYMETHOXY)-4-METHYLPENTYL]SULFANYL}-1-PHENYL-1H-TETRAAZOLE | C21H36N4O3SSi | 1217443-73-6 | Details |
| Monoclonal Anti-ATP6V1A, (C-terminal) antibody produced in mouse | Details |
| 2,6-Dibromo-4-(6-methylbenzo[d]thiazol-2-yl)aniline | C14H10Br2N2S | Details |
| IMP-1575 | Details |
| N'-(2-PYRIDINYLMETHYLENE)BENZOHYDRAZIDE | C13H11N3O | 270576-10-8 | Details |
| op18 (AB2) Blocking Peptide for PRS4237 | Details |
| Locking clip NA25 black alumin, w/screw | Details |
| 1-[2-(1-naphthyloxy)-2-phenylethyl]pyrrolidine hydrochloride | Details |
| 3,7-bis(ethylamino)-2,8-dimethyl-5-phenylphenazin-5-ium chloride | C24H27ClN4 | 122142-77-2 | Details |
| Anti-PGM2L1 antibody produced in rabbit | Details |
| 3-[(4-CHLOROANILINO)METHYL]-1-(2-OXO-2-PHENYLETHYL)-6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[4,5-A]AZEPIN-1-IUM BROMIDE | C22H24BrClN4O | 1036707-59-1 | Details |
| N-(4-CHLOROBENZYL)-L-THREONINE | 196792-42-4 | Details |
| 3,4-DIMETHOXYBENZALDEHYDE (6-TERT-PENTYL-5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4-YL)HYDRAZONE | C24H30N4O2S | 314770-21-3 | Details |
| 4-((5-ALLYL-2-IMINO-4,6-DIOXOHEXAHYDRO-5-PYRIMIDINYL)METHYL)BENZOIC ACID | 85301-59-3 | Details |
| [9-CHLORO-2-(2-NAPHTHYL)-1,10B-DIHYDROPYRAZOLO[1,5-C][1,3]BENZOXAZIN-5-YL](4-METHYLPHENYL)METHANONE | C28H21ClN2O2 | 303060-44-8 | Details |
| Benztropine Related Compound A | C20H24ClNO | 25471-67-4 | Details |
| Uricase from Candida sp. | C18H26N5O14P | 9002-12-4 | Details |
| 4-(2-((4-ISOPROPYLPHENOXY)AC)CARBOHYDRAZONOYL)-2-METHOXYPHENYL 4-PROPOXYBENZOATE | C29H32N2O6 | 881457-46-1 | Details |
| 4-Bromo-3-methyl-1H-pyrazole-5-carboxylic acid | C5H5BrN2O2 | 861382-63-0 | Details |
| Sudan Blue II | C22H26N2O2 | 17354-14-2 | Details |
| (1-(3-CHLORO-4-FLUOROPHENYL)-3-(3-PYRIDINYL)-1H-PYRAZOL-4-YL)METHANOL | C15H11ClFN3O | 618444-58-9 | Details |
| 1,1-DIMETHYL-3-(3-METHOXYPHENYL)UREA | C10H14N2O2 | 28170-54-9 | Details |
| Pellicon? 2 Maxi Cassette with BIOMAX 100 kDa Membrane, V screen, 2 m2 | Details |
| Pyrex? Gooch crucible, low form, with fritted disc | Details |
| Product Total： Product Page： | ||||
| 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 | ||||